HCA
RVMD icon

Harbor Capital Advisors’s Revolution Medicines RVMD Stock Holding History

Harbor Capital Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,076
Closed -$1.68M – 1452
2025
Q4 		$1.68M Sell
21,076
-514
-2% -$33.7K 0.13% 214
2025
Q3 		$1.01M Sell
21,590
-36,733
-63% -$1.44M 0.08% 320
2025
Q2 		$2.15M Buy
58,323
+22,906
+65% +$880K 0.09% 281
2025
Q1 		$1.25M Buy
+35,417
New +$1.44M 0.06% 388

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Harbor Capital Advisors's RVMD Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 21,076 shares — an estimated $1.68M sold.

Harbor Capital Advisors first reported a position in RVMD in Q1 2025 and held it in 4 quarters. The position peaked at $2.15M in Q2 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 21,076 Revolution Medicines shares in Q1 2026, an estimated $1.68M.
  • Harbor Capital Advisors first reported a position in Revolution Medicines in Q1 2025 and held it in 4 quarters.
  • Harbor Capital Advisors's Revolution Medicines position peaked at $2.15M in Q2 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.